Supplemental material
Infectious Diseases
Economic evaluation using dynamic transition modeling of ebola virus vaccination in lower-and-middle-income countries
Mavis Obeng-Kusia Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USA
https://orcid.org/0000-0001-6159-6782
https://orcid.org/0000-0001-6159-6782, Magdiel A. Habilaa Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USA;b Mel & Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USAhttps://orcid.org/0000-0003-4614-7772
https://orcid.org/0000-0003-4614-7772, Denise J. Roeb Mel & Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USAhttps://orcid.org/0000-0001-6989-6579
https://orcid.org/0000-0001-6989-6579, Brian Erstadc Pharmacy Practice and Science, University of Arizona, Tucson, AZ, USAhttps://orcid.org/0000-0001-8909-9921
https://orcid.org/0000-0001-8909-9921 & Ivo Abrahama Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ, USACorrespondence[email protected]
https://orcid.org/0000-0003-0490-4421
https://orcid.org/0000-0003-0490-4421Related Research Data
Economic evaluation using dynamic transition modeling of ebola virus vaccination in lower-and-middle-income countries
Source:
Taylor & Francis
Linking provided by
